Curis Lifesciences Limited (NSE:CURIS)
India flag India · Delayed Price · Currency is INR
112.00
+3.00 (2.75%)
At close: Jul 20, 2026

Curis Lifesciences Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
69.1661.0548.6718.754.92
Depreciation & Amortization
6.966.756.797.267.55
Loss (Gain) From Sale of Assets
-0.09---0.11-0.05
Other Operating Activities
12.8417.0231.4416.3223.54
Change in Accounts Receivable
-36.3925.72-5.5-32.520.59
Change in Inventory
-157.09-94.38-38.542.68-24.39
Change in Accounts Payable
21.81-9.48-41.7517.8135.08
Change in Other Net Operating Assets
-81.37-24.311.693.372.21
Operating Cash Flow
-164.16-17.632.833.5549.46
Operating Cash Flow Growth
---91.65%-32.17%-
Capital Expenditures
-18.02-0.93-0.73-6.23-3.99
Sale of Property, Plant & Equipment
0.2--0.450.14
Other Investing Activities
1.930.70.120.230.12
Investing Cash Flow
-15.89-0.24-0.62-5.56-3.73
Short-Term Debt Issued
--19.7121.81
Total Debt Issued
--19.7121.81
Short-Term Debt Repaid
--2.69---
Long-Term Debt Repaid
-19.19-12.02-10.74-26.3-31.43
Total Debt Repaid
-19.19-14.71-10.74-26.3-31.43
Net Debt Issued (Repaid)
-19.19-14.718.96-14.3-29.63
Issuance of Common Stock
239.2442.5---
Other Financing Activities
-11.39-11.06-8.49-13.28-16.16
Financing Cash Flow
208.6616.720.47-27.58-45.79
Miscellaneous Cash Flow Adjustments
-0---
Net Cash Flow
28.62-1.142.650.41-0.05
Free Cash Flow
-182.18-18.562.0727.3145.47
Free Cash Flow Growth
---92.42%-39.93%-
Free Cash Flow Margin
-30.05%-3.74%0.58%7.70%19.15%
Free Cash Flow Per Share
-27.02-3.130.354.638.27
Cash Interest Paid
11.3911.068.4913.2816.16
Cash Income Tax Paid
22.6215.56---
Levered Free Cash Flow
-283.49-39.11-19.023.5324.51
Unlevered Free Cash Flow
-276.37-32.2-13.7211.8334.61
Change in Working Capital
-253.04-102.44-84.1-8.6713.49